ResearcherHamamatsu UniversityActive in the last 2 years
Shintaro Ichikawa
Matched on ORCID iD 0000-0001-8043-8472; OpenAlex author ID A5008248425. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 7
- Open-source offline-deployable retrieval-augmented large language model for assisting pancreatic cancer staging. Last author DOI 10.1007/s11604-026-02049-8↗
- Algorithmic implementation of pancreatic cancer staging guidelines: comparison with a retrieval-augmented large language model Co-author DOI 10.64898/2026.06.30.26356912↗
- [Imaging findings of intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma]. Co-author DOI 10.11405/nisshoshi.119.1055↗
- Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pan… Co-author DOI 10.1007/s00261-020-02695-0↗
- Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraducta… Co-author DOI 10.1097/md.0000000000018039↗
- Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer. First author DOI 10.1007/s00261-018-1647-4↗
- Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer. Co-author DOI 10.21873/anticanres.13019↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazunori Nakamoto · 2 shared papers, 2026 · strength 0.56
- Paper Open-source offline-deployable retrieval-augmented large language model for assisting pancreatic cancer staging. DOI 10.1007/s11604-026-02049-8↗
- Paper Algorithmic implementation of pancreatic cancer staging guidelines: comparison with a retrieval-augmented large languag… DOI 10.64898/2026.06.30.26356912↗
- Atsushi Komaba · 2 shared papers, 2026 · strength 0.56
- Paper Open-source offline-deployable retrieval-augmented large language model for assisting pancreatic cancer staging. DOI 10.1007/s11604-026-02049-8↗
- Paper Algorithmic implementation of pancreatic cancer staging guidelines: comparison with a retrieval-augmented large languag… DOI 10.64898/2026.06.30.26356912↗
- Hisashi Johno · 2 shared papers, 2026 · strength 0.56
- Paper Open-source offline-deployable retrieval-augmented large language model for assisting pancreatic cancer staging. DOI 10.1007/s11604-026-02049-8↗
- Paper Algorithmic implementation of pancreatic cancer staging guidelines: comparison with a retrieval-augmented large languag… DOI 10.64898/2026.06.30.26356912↗
- Hiroshi Onishi · 3 shared papers, 2018–2021 · strength 0.36
- Paper Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal… DOI 10.1007/s00261-020-02695-0↗
- Paper Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with p… DOI 10.1007/s00261-018-1647-4↗
- Paper Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal ad… DOI 10.1097/md.0000000000018039↗
- Satoshi Goshima · 1 shared paper, 2022 · strength 0.33
- Shinichi Takano · 2 shared papers, 2018–2019 · strength 0.13
- Paper Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal ad… DOI 10.1097/md.0000000000018039↗
- Paper Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer. DOI 10.21873/anticanres.13019↗
- Hiromichi Kawaida · 2 shared papers, 2018–2019 · strength 0.13
- Paper Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal ad… DOI 10.1097/md.0000000000018039↗
- Paper Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer. DOI 10.21873/anticanres.13019↗
- Yoshie Omiya · 1 shared paper, 2018 · strength 0.10
- Satoshi Kawakami · 1 shared paper, 2019 · strength 0.07
- Makoto Kadokura · 1 shared paper, 2019 · strength 0.07
- Nobuyuki Enomoto · 1 shared paper, 2019 · strength 0.07
- Hiroshi Kono · 1 shared paper, 2018 · strength 0.06
- Daisuke Ichikawa · 1 shared paper, 2018 · strength 0.06
- Hideki Fujii · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.